UNSPSC 51373409: Ammonium/antimony/codeine/phenylephrine/potassium/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373409 Ammonium/antimony/codeine/phenylephrine/potassium/pyrilamine, a Commodity code, covers pharmaceutical and over-the-counter products that state and local governments procure through direct purchase and cooperative purchasing vehicles. The code encompasses both specialty pharmaceuticals (notably naloxone for overdose response) and multi-source generic drugs distributed through authorized wholesalers to state agencies, county health departments, and participating municipalities. Issuing bodies include county health systems, state procurement offices administering cooperative purchasing alliances, and state departments of administration sourcing products for distributed government facilities. Vendors must comply with cGMP certification, FDA requirements, Drug Supply Chain Security Act (DSCSA) compliance, and maintain contractual relationships with authorized pharmaceutical wholesalers when applicable.

Recent activity spans Florida and Minnesota-led interstate cooperative purchasing. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, responding by July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, establishing statewide and multi-state contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with proposals due March 26, 2026 and awards effective July 1, 2026. MMCAP's evaluation weights price competitiveness at 75 percent, with vendors paying a 3 percent administrative fee on all purchases and subject to performance penalties of $200 to $1,500 per violation.